Found: 4
Select item for more details and to access through your institution.
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock.
- Published in:
- Annals of Intensive Care, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13613-023-01227-5
- By:
- Publication type:
- Article
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 800, doi. 10.1002/ajh.24415
- By:
- Publication type:
- Article